Xinghui He

Luzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Cathepsin-Triggered Size-Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis.

A Cathepsin-Triggered Size-Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis.

Journal: Advanced healthcare materials

Published: February 18, 2026

Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy.

Advances in nanodelivery systems based on tumor-associated cell reprogramming strategies for enhanced tumor therapy.

Journal: Acta biomaterialia

Published: February 05, 2026

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.

Journal: Colloids and surfaces. B, Biointerfaces

Published: January 27, 2026

NIR-controlled photothermal intelligent nanozyme synergizes catalysis and gas therapy for multidimensional treatment of inflammatory bowel disease.

NIR-controlled photothermal intelligent nanozyme synergizes catalysis and gas therapy for multidimensional treatment of inflammatory bowel disease.

Journal: Journal of nanobiotechnology

Published: September 09, 2025

A shikonin/Cu2+ coordination complex-encapsulated hydrogel drug depot alleviates myocardial ischemia-reperfusion injury by disrupting energy metabolism-mediated intercellular crosstalk.

A shikonin/Cu2+ coordination complex-encapsulated hydrogel drug depot alleviates myocardial ischemia-reperfusion injury by disrupting energy metabolism-mediated intercellular crosstalk.

Journal: Journal of colloid and interface science

Published: July 24, 2025

Recent Advances in Nanodelivery Systems Based on Extracellular and Intracellular Reprogramming Strategies for Enhanced Therapy of Atherosclerosis.

Recent Advances in Nanodelivery Systems Based on Extracellular and Intracellular Reprogramming Strategies for Enhanced Therapy of Atherosclerosis.

Journal: International journal of nanomedicine

Published: June 10, 2025

Size-adjustable nanoparticles co-target macrophages and endothelial cells for enhanced atherosclerosis therapy.

Size-adjustable nanoparticles co-target macrophages and endothelial cells for enhanced atherosclerosis therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: May 09, 2025

Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review.

Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review.

Journal: Frontiers in endocrinology

Published: March 07, 2025

Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis.

Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis.

Journal: Journal of drug targeting

Published: November 27, 2024

Advances in nanodelivery systems based on apoptosis strategies for enhanced rheumatoid arthritis therapy.

Advances in nanodelivery systems based on apoptosis strategies for enhanced rheumatoid arthritis therapy.

Journal: Acta biomaterialia

Published: November 26, 2024

Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy.

Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy.

Journal: International journal of nanomedicine

Published: May 07, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026